When Tumor Suppressor TGFβ Meets the HER2 (ERBB2) Oncogene

Author： Chow Amy  

Publisher： Springer Publishing Company

ISSN： 1083-3021

Source： Journal of Mammary Gland Biology and Neoplasia, Vol.16, Iss.2, 2011-06, pp. : 81-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors

By  

GENES, CHROMOSOMES AND CANCER, Vol. 57, Iss. 4, 2018-04 ,pp. : 182-191

John Wiley & Sons Inc

Access to resources Recommend Favorite

When activated oncogene meets immunity: A fight to prevent liver tumor initiation

By  

HEPATOLOGY, Vol. 56, Iss. 1, 2012-07 ,pp. : 387-389

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mammalian SIRT2 inhibits keratin 19 expression and is a tumor suppressor in skin

By  

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 23, Iss. 3, 2014-03 ,pp. : 207-209

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vitamin D Receptor Gene BsmI Polymorphism Correlates with erbB-2/HER-2 Expression in Human Rectal Cancer

By  

Oncology, Vol. 58, Iss. 3, 2000-04 ,pp. : 242-247

Karger

Access to resources Recommend Favorite

Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti‐HER2 targeted therapies

By  

CANCER, Vol. 122, Iss. 17, 2016-09 ,pp. : 2654-2662

John Wiley & Sons Inc

Access to resources Recommend Favorite